Kayne Anderson Rudnick Investment Management
ONC

Kayne Anderson Rudnick Investment Management’s BeOne Medicines Ltd ONC Stock Holding History

Kayne Anderson Rudnick Investment Management’s Portfolio ONC Stock Details ONC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$676K Buy
2,371
+92
+4% +$27.1K ﹤0.01% 455
2026
Q1 		$677K Buy
2,279
+173
+8% +$56K ﹤0.01% 409
2025
Q4 		$640K Buy
2,106
+122
+6% +$39.9K ﹤0.01% 427
2025
Q3 		$676K Buy
1,984
+349
+21% +$106K ﹤0.01% 413
2025
Q2 		$396K Buy
1,635
+1,480
+955% +$363K ﹤0.01% 449
2025
Q1 		$42.2K Buy
+155
New +$36.2K ﹤0.01% 595
2024
Q1 		– Sell
-1
Closed -$180 – 1004
2023
Q4 		$180 Hold
1
– – ﹤0.01% 928
2023
Q3 		$180 Hold
1
– – ﹤0.01% 840
2023
Q2 		$178 Hold
1
– – ﹤0.01% 840
2023
Q1 		$216 Buy
+1
New +$240 ﹤0.01% 714
2022
Q1 		– Sell
-1
Closed – – 730
2021
Q4 		$0 Buy
+1
New +$338 ﹤0.01% 663

Other funds holding ONC

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Kayne Anderson Rudnick Investment Management's ONC Position: Q2 2026 in Review

Kayne Anderson Rudnick Investment Management increased its BeOne Medicines Ltd (ONC) stake by 4% in Q2 2026, buying an estimated $27.1K and bringing the position to 2,371 shares worth $676K. The position accounts for ﹤0.01% of the portfolio, ranked #455.

Kayne Anderson Rudnick Investment Management first reported a position in ONC in Q4 2021 and has held it in 11 quarters since. The position peaked at $677K in Q1 2026. 282 funds tracked by Wall St. Rank hold ONC as of Q2 2026.

  • Kayne Anderson Rudnick Investment Management held 2,371 shares of BeOne Medicines Ltd worth $676K as of Q2 2026.
  • Kayne Anderson Rudnick Investment Management bought 92 BeOne Medicines Ltd shares in Q2 2026, an estimated $27.1K.
  • BeOne Medicines Ltd made up ﹤0.01% of Kayne Anderson Rudnick Investment Management's portfolio in Q2 2026, its #455 holding.
  • Kayne Anderson Rudnick Investment Management first reported a position in BeOne Medicines Ltd in Q4 2021 and has held it in 11 quarters since.
  • Kayne Anderson Rudnick Investment Management's BeOne Medicines Ltd position peaked at $677K in Q1 2026.
  • 282 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q2 2026.

Based on Kayne Anderson Rudnick Investment Management's 13F filing for Q2 2026, filed 13 Aug 2026.